α3β1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutics for Non-Small Cell Lung Cancer Treatment
2020
Docetaxel (DTX) widely used for treating non-small cell lung cancer (NSCLC) patients is associated with dose-limiting side effects primarily neurotoxicity and myelosuppression. Here, we have develo...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
50
References
12
Citations
NaN
KQI